Mylan (MYL) - 31 Year Stock Split History

Historical stock splits for Mylan since 1987. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Mylan Annual Stock Splits
Mylan Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $19.499B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $62.621B 10.74
Teva Pharmaceutical Industries (TEVA) Israel $22.849B 6.38
Bausch Health Cos (BHC) Canada $7.285B 5.44
Dr Reddy's Laboratories (RDY) India $5.340B 23.85
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.698B 4.59
Akorn (AKRX) United States $2.422B 11.99
Supernus Pharmaceuticals (SUPN) United States $2.258B 24.16
Assembly Biosciences (ASMB) United States $0.913B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.809B 116.67
CymaBay Therapeutics (CBAY) United States $0.706B 0.00
Homology Medicines (FIXX) United States $0.622B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.604B 0.00
Voyager Therapeutics (VYGR) United States $0.593B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.590B 0.00
Corium (CORI) United States $0.319B 0.00
Teligent (TLGT) United States $0.225B 0.00
Sol-Gel Technologies (SLGL) Israel $0.118B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.111B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.067B 0.00
Aevi Genomic Medicine (GNMX) United States $0.066B 0.00
Versartis (VSAR) United States $0.062B 0.00
Evoke Pharma (EVOK) United States $0.039B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.022B 0.00
Acasti Pharma (ACST) Canada $0.017B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00
Agile Therapeutics (AGRX) United States $0.009B 0.00